Watson introduces generic LoSEASONIQUE
The launch follows a settlement with Teva Women’s Health. The global marketing research company for the pharmaceutical industry, IMS Health said Watson is the first applicant to submit
Isomorphic Labs has raised $5bn in a Series C financing round to support the development of its AI platform and advance its therapeutic candidates towards clinical evaluation.
The trial evaluated the safety, pharmacokinetics and pharmacodynamics of subcutaneous administration of Cinryze in combination with Halozyme’s Enhanze technology in hereditary angioedema (HAE). Enhanze technology is a drug